For: | Lapinski TW, Flisiak R, Jaroszewicz J, Michalewicz M, Kowalczuk O. Efficiency and safety of lamivudine therapy in patients with chronic HBV infection, dialysis or after kidney transplantation. World J Gastroenterol 2005; 11(3): 400-402 [PMID: 15637753 DOI: 10.3748/wjg.v11.i3.400] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i3/400.htm |
Number | Citing Articles |
1 |
J. Chudek, A. Kolonko, J. Ficek, H. Karkoszka, B. Baka‐Ćwierz, A. Więcek. A case of acute rejection shortly after initiation of lamivudine therapy in a simultaneous pancreas and kidney recipient with viral hepatitis type B. Transplant Infectious Disease 2009; 11(6): 553 doi: 10.1111/j.1399-3062.2009.00442.x
|
2 |
C. Pipili, E. Cholongitas, G. Papatheodoridis. Review article: nucleos(t)ide analogues in patients with chronic hepatitis B virus infection and chronic kidney disease. Alimentary Pharmacology & Therapeutics 2014; 39(1): 35 doi: 10.1111/apt.12538
|
3 |
MATTHEW EDEY, KATHERINE BARRACLOUGH, DAVID W JOHNSON. Review article: Hepatitis B and dialysis. Nephrology 2010; 15(2): 137 doi: 10.1111/j.1440-1797.2009.01268.x
|
4 |
Fabrizio Fabrizi, Piergiorgio Messa, Carlo Basile, Paul Martin. Hepatic disorders in chronic kidney disease. Nature Reviews Nephrology 2010; 6(7): 395 doi: 10.1038/nrneph.2010.37
|
5 |
Eugene Kwon, Jang-Hee Cho, Hye Min Jang, Yon Su Kim, Shin-Wook Kang, Chul Woo Yang, Nam-Ho Kim, Hyun-Ji Kim, Jeung-Min Park, Ji-Eun Lee, Hee-Yeon Jung, Ji-Young Choi, Sun-Hee Park, Chan-Duck Kim, Yong-Lim Kim, Ferruccio Bonino. Differential Effect of Viral Hepatitis Infection on Mortality among Korean Maintenance Dialysis Patients: A Prospective Multicenter Cohort Study. PLOS ONE 2015; 10(8): e0135476 doi: 10.1371/journal.pone.0135476
|
6 |
Fabrizio Fabrizi, Piergiorgio Messa, Vivek Dixit, Paul Martin. Therapy with Nucleos(t)ide Analogues: Current Role in Dialysis Patients. The International Journal of Artificial Organs 2010; 33(6): 329 doi: 10.1177/039139881003300601
|
7 |
A. Potthoff, H. L. Tillmann, C. Bara, K. Deterding, K. Pethig, S. Meyer, A. Haverich, K. H. W. Böker, M. P. Manns, H. Wedemeyer. Improved outcome of chronic hepatitis B after heart transplantation by long‐term antiviral therapy. Journal of Viral Hepatitis 2006; 13(11): 734 doi: 10.1111/j.1365-2893.2006.00748.x
|
8 |
Fabrizio Fabrizi, Vivek Dixit, Piergiorgio Messa, Paul Martin. Management of Chronic Hepatitis B in Special Populations: Immunosuppressed Patients and Chronic Kidney Disease. Current Hepatitis Reports 2011; 10(4): 269 doi: 10.1007/s11901-011-0116-0
|
9 |
Stefan Wirth. Antiviral treatment of hepatitis B following solid organ transplantation in children. Pediatric Transplantation 2006; 10(3): 271 doi: 10.1111/j.1399-3046.2006.00500.x
|
10 |
Adam E. Mikolajczyk, Andrew I. Aronsohn. Current Management of Chronic Hepatitis B and C in Chronic Kidney Disease. Advances in Chronic Kidney Disease 2015; 22(5): 352 doi: 10.1053/j.ackd.2015.06.008
|
11 |
C. Molino, F. Fabbian, M. Cozzolino, C. Longhini. The Management of Viral Hepatitis in CKD Patients: An Unresolved Problem. The International Journal of Artificial Organs 2008; 31(8): 683 doi: 10.1177/039139880803100802
|
12 |
Kai-Uwe Eckardt, Bertram L. Kasiske, Martin G. Zeier. Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients. American Journal of Transplantation 2009; 9: S1 doi: 10.1111/j.1600-6143.2009.02834.x
|
13 |
L. Filik, H. Karakayalı, G. Moray, A. Dalgıç, R. Emiroğlu, N. Özdemir, T. Çolak, G. Gür, U. Yılmaz, M. Haberal. Lamivudine Therapy in Kidney Allograft Recipients Who Are Seropositive for Hepatitis B Surface Antigen. Transplantation Proceedings 2006; 38(2): 496 doi: 10.1016/j.transproceed.2005.12.047
|
14 |
Fabrizio Fabrizi, Piergiorgio Messa, Paul Martin. Hepatitis B Virus Infection and the Dialysis Patient. Seminars in Dialysis 2008; 21(5): 440 doi: 10.1111/j.1525-139X.2008.00437.x
|
15 |
F. Fabrizi, A. Marzano, P. Messa, P. Martin, P. Lampertico. Hepatitis B Virus Infection in the Dialysis Population: Current Perspectives. The International Journal of Artificial Organs 2008; 31(5): 386 doi: 10.1177/039139880803100503
|
16 |
Fabrizio Fabrizi, Paul Martin. Management of hepatitis B and C virus infection before and after renal transplantation. Current Opinion in Organ Transplantation 2006; 11(6): 583 doi: 10.1097/MOT.0b013e3280105c5c
|
17 |
Javier Fuentes Olmo, Rafael Uribarrena Amézaga. Tratamiento actual de la hepatitis B: ¿dónde encajan los nuevos análogos de los núcleos(t)idos?. Gastroenterología y Hepatología 2011; 34(7): 492 doi: 10.1016/j.gastrohep.2011.02.009
|
18 |
Behzad Einollahi. Therapy for HBV Infection in Hemodialysis Patients: Is it Possible?. Hepatitis Monthly 2012; 12(3): 153 doi: 10.5812/hepatmon.5081
|
19 |
Florence Wong. Renal Diseases and the Liver. Clinics in Liver Disease 2011; 15(1): 39 doi: 10.1016/j.cld.2010.09.011
|
20 |
Marion G. Peters. Special populations with hepatitis B virus infection #. Hepatology 2009; 49(Suppl. 5): S146 doi: 10.1002/hep.22965
|
21 |
G.‐D. Chen, J.‐L. Gu, J. Qiu, L.‐Z. Chen. Outcomes and risk factors for hepatitis B virus (HBV) reactivation after kidney transplantation in occult HBV carriers. Transplant Infectious Disease 2013; 15(3): 300 doi: 10.1111/tid.12065
|
22 |
Fabrizio Fabrizi, Mauro Viganò, Giovanni Banfi, Paul Martin, Piergiorgio Messa, Pietro Lampertico. Hbv-Related Liver Disease in Renal Insufficiency: Successful Antiviral Therapy with Entecavir. The International Journal of Artificial Organs 2011; 34(10): 1031 doi: 10.5301/ijao.5000063
|
23 |
Irene N Rapti, Stephanos J Hadziyannis. Treatment of special populations with chronic hepatitis B infection. Expert Review of Gastroenterology & Hepatology 2011; 5(3): 323 doi: 10.1586/egh.11.7
|
24 |
Martina Spaziante, Elisa Biliotti, Stefania Grieco, Donatella Palazzo, Rozenn Esvan, Gloria Taliani. Anti‐HBs seroconversion during treatment with entecavir in a patient with chronic hepatitis B virus infection on hemodialysis. Journal of Medical Virology 2014; 86(1): 139 doi: 10.1002/jmv.23795
|